% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Kardell:298618,
author = {O. Kardell and T. Gronauer and C. von Toerne and J.
Merl-Pham and A.-C. König and T. K. Barth and J. Mergner
and C. Ludwig and J. Tüshaus and P. Giesbertz and S.
Breimann and L. Schweizer and T. Müller$^*$ and G.
Kliewer$^*$ and U. Distler and D. Gómez-Zepeda$^*$ and O.
Popp and D. Qin and D. Teupser and J. Cox and A. Imhof and
B. Küster and S. F. Lichtenthaler and J. Krijgsveld$^*$ and
S. Tenzer and P. Mertins and F. Coscia and S. M. Hauck},
title = {{M}ulticenter {L}ongitudinal {Q}uality {A}ssessment of
{MS}-{B}ased {P}roteomics in {P}lasma and {S}erum.},
journal = {Journal of proteome research},
volume = {24},
number = {3},
issn = {1535-3893},
address = {Washington, DC},
publisher = {ACS Publications},
reportid = {DKFZ-2025-00318},
pages = {1017-1029},
year = {2025},
note = {HI-TRON / 2025 Mar 7;24(3):1017-1029},
abstract = {Advancing MS-based proteomics toward clinical applications
evolves around developing standardized start-to-finish and
fit-for-purpose workflows for clinical specimens. Steps
along the method design involve the determination and
optimization of several bioanalytical parameters such as
selectivity, sensitivity, accuracy, and precision. In a
joint effort, eight proteomics laboratories belonging to the
MSCoreSys initiative including the CLINSPECT-M, MSTARS,
DIASyM, and SMART-CARE consortia performed a longitudinal
round-robin study to assess the analysis performance of
plasma and serum as clinically relevant samples. A variety
of LC-MS/MS setups including mass spectrometer models from
ThermoFisher and Bruker as well as LC systems from
ThermoFisher, Evosep, and Waters Corporation were used in
this study. As key performance indicators, sensitivity,
precision, and reproducibility were monitored over time.
Protein identifications range between 300 and 400 IDs across
different state-of-the-art MS instruments, with timsTOF Pro,
Orbitrap Exploris 480, and Q Exactive HF-X being among the
top performers. Overall, 71 proteins are reproducibly
detectable in all setups in both serum and plasma samples,
and 22 of these proteins are FDA-approved biomarkers, which
are reproducibly quantified (CV < $20\%$ with label-free
quantification). In total, the round-robin study highlights
a promising baseline for bringing MS-based measurements of
serum and plasma samples closer to clinical utility.},
keywords = {LC-MS/MS (Other) / R package mpwR (Other) / clinical
specimen (Other) / longitudinal round-robin study (Other) /
plasma (Other) / serum (Other)},
cin = {B230},
ddc = {540},
cid = {I:(DE-He78)B230-20160331},
pnm = {312 - Funktionelle und strukturelle Genomforschung
(POF4-312)},
pid = {G:(DE-HGF)POF4-312},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:39918541},
doi = {10.1021/acs.jproteome.4c00644},
url = {https://inrepo02.dkfz.de/record/298618},
}